Dr Bozza coordinates the critical care and infectious disease research on the largest integrated hospital network in Latin America (IDOR-Rede D’Or São Luiz). The network is present in ten Brazilian States and comprises 63 hospitals.
Dr Fernando Bozza’s research activities involve clinical and translational research on severe emerging and reemerging infectious diseases, antimicrobial resistance, and the neuro-cognitive consequences of severe infections. He has also acted in the consolidation of collaborative clinical research initiatives in Brazil and Latin America, such as the Brazilian Intensive Care Research Network, where he was the founder and first president.
Dr Bozza’s research group has made significant contributions to managing emerging infectious diseases, including studies on dengue, Zika, Chikungunya, yellow fever, and COVID-19. Bozza has more than 250 peer reviewed papers, including publications in high-impact journals such as NEJM, JAMA, Nature, Lancet Infectious Diseases, Lancet Respiratory Medicine, Emerging infectious diseases, etc.
Furthermore, Dr Bozza is grantee of the ICODA (International COVID-19 Data Alliance) Challenge, supported by Health Data Research UK (HDRUK) the and Bill & Melinda Gates foundation, being Principal Investigator of the EFFECT-Brazil project, which aims to evaluate the COVID-19 vaccine effectiveness in Brazil using statistical and machine learning models. His team comprises biomedical researchers, physicians, epidemiologists, engineers, and statisticians.